Achieve Life Sciences
ACHV
64 hedge funds and large institutions have $81.2M invested in Achieve Life Sciences in 2024 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 19 increasing their positions, 11 reducing their positions, and 3 closing their positions.
1,739% more call options, than puts
Call options by funds: $1.8M | Put options by funds: $98K
300% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 3
73% more repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 11
14% more funds holding
Funds holding: 56 → 64 (+8)
4% more capital invested
Capital invested by funds: $78.4M → $81.2M (+$2.81M)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
4.79% less ownership
Funds ownership: 54.1% → 49.3% (-4.8%)
Top Buyers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.99M |
| 2 |
Northern Trust
Chicago,
Illinois
|
+$1.13M |
| 3 |
Goldman Sachs
New York
|
+$915K |
| 4 |
SI
Sofinnova Investments
Menlo Park,
California
|
+$574K |
| 5 |
BlackRock
New York
|
+$524K |
Top Sellers
| 1 |
Franklin Resources
San Mateo,
California
|
-$9.96M |
| 2 |
ACM
ADAR1 Capital Management
Austin,
Texas
|
-$2.48M |
| 3 |
ACM
Altium Capital Management
New York
|
-$1.02M |
| 4 |
Bank of New York Mellon
New York
|
-$116K |
| 5 |
New York State Common Retirement Fund
Albany,
New York
|
-$94.1K |
ACHV Hedge Fund Activity: Q3 2024 in Review
64 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Achieve Life Sciences (ACHV) for Q3 2024, worth a combined $81.2M — up 3.6% from $78.4M a quarter earlier.
Buyers outnumbered sellers: 12 funds opened new ACHV positions and 3 closed out — a net gain of 9 holders — while 19 added to existing stakes and 11 trimmed.
The largest buyer was Vanguard Group, adding an estimated $1.99M. The largest seller was Franklin Resources, cutting an estimated $9.96M.
- 64 institutional investors held Achieve Life Sciences (ACHV) as of Q3 2024, up from 56 in Q2 2024.
- Funds reported $81.2M of Achieve Life Sciences stock for Q3 2024, up 3.6% quarter-over-quarter.
- 12 funds opened new Achieve Life Sciences positions in Q3 2024 and 3 closed out, a net change of +9 holders.
- The largest Achieve Life Sciences buyer in Q3 2024 was Vanguard Group, an estimated $1.99M added.
- The largest Achieve Life Sciences seller in Q3 2024 was Franklin Resources, an estimated $9.96M sold.
Based on aggregated 13F filings for Q3 2024.